To our knowledge, this is the first study to characterize neuropsychiatric phenotypes in a longitudinally evaluated case series of patients with PPA and bvFTD due to autopsy-confirmed FTLD-tau. The gene discussed is MAPT; the disease is primary progressive aphasia.